ArticleCells2023

Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS).

Ellery Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.